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Abstract
Advances in biotechnology continue to drive the development of a wide range of insect-protected, herbicide-
tolerant, stress-tolerant, and nutritionally enhanced genetically modified (GM) crops, yet societal and public
policy considerations may slow their commercialization. Such restrictions may disproportionately affect
developing countries, as well as smaller entrepreneurial and public sector initiatives. The 2014 IUPAC
International Congress of Pesticide Chemistry (San Francisco, CA, USA; August 2014) included a
symposium on “Challenges Associated with Global Adoption of Agricultural Biotechnology” to review
current obstacles in promoting GM crops. Challenges identified by symposium presenters included (i) poor
public understanding of GM technology and the need for enhanced communication strategies, (ii)
nonharmonized and prescriptive regulatory requirements, and (iii) limited experience with regulations and
product development within some public sector programs. The need for holistic resistance management
programs to enable the most effective use of insect-protected crops was also a point of emphasis. This paper
provides details on the symposium discussion and provides background information that can be used in
support of further adoption of beneficial GM crops. Overall, it emphasizes that global adoption of modern
agricultural biotechnology has not only provided benefits to growers and consumers but has great potential to
provide solutions to an increasing global population and diminishing agricultural land. This potential will be
realized by continued scientific innovation, harmonized regulatory systems, and broader communication of
the benefits of the high-yielding, disease-resistant, and nutritionally enhanced crops attainable through
modern biotechnology.
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ABSTRACT: Advances in biotechnology continue to drive the development of a wide range of insect-protected, herbicide-
tolerant, stress-tolerant, and nutritionally enhanced genetically modiﬁed (GM) crops, yet societal and public policy
considerations may slow their commercialization. Such restrictions may disproportionately aﬀect developing countries, as well as
smaller entrepreneurial and public sector initiatives. The 2014 IUPAC International Congress of Pesticide Chemistry (San
Francisco, CA, USA; August 2014) included a symposium on “Challenges Associated with Global Adoption of Agricultural
Biotechnology” to review current obstacles in promoting GM crops. Challenges identiﬁed by symposium presenters included (i)
poor public understanding of GM technology and the need for enhanced communication strategies, (ii) nonharmonized and
prescriptive regulatory requirements, and (iii) limited experience with regulations and product development within some public
sector programs. The need for holistic resistance management programs to enable the most eﬀective use of insect-protected
crops was also a point of emphasis. This paper provides details on the symposium discussion and provides background
information that can be used in support of further adoption of beneﬁcial GM crops. Overall, it emphasizes that global adoption of
modern agricultural biotechnology has not only provided beneﬁts to growers and consumers but has great potential to provide
solutions to an increasing global population and diminishing agricultural land. This potential will be realized by continued
scientiﬁc innovation, harmonized regulatory systems, and broader communication of the beneﬁts of the high-yielding, disease-
resistant, and nutritionally enhanced crops attainable through modern biotechnology.
KEYWORDS: agricultural biotechnology, genetically modiﬁed crops, regulatory assessments
■ INTRODUCTION
Technical advances in biotechnology are driving the develop-
ment of improved insect-protected, herbicide-tolerant, stress-
tolerant, and nutritionally enhanced crops. Since their ﬁrst
commercialization in 1996, the cultivation area of genetically
modiﬁed (GM) crops has increased every year, including 12
years of double-digit growth.1 In 2014, GM crops were planted
by a record 18 million farmers in 28 countries encompassing a
total of 181.5 million hectares. However, despite convincing
scientiﬁc evidence of the beneﬁts1,2 and safety2,3 of GM crops,
societal factors and well-funded opposition continue to foster
resistance to modern agricultural technology.4 For example,
concerns over a potential consumer backlash in the United
States has hindered the commercialization of a nutritionally
beneﬁcial potato;5 even products with life-saving potential, such
as Golden Rice, have faced opposition.6
Improved crop varieties are the cornerstone of agricul-
ture.7−11 To meet the challenges of population growth,
diminishing high-quality agricultural production land, and
rapid urbanization, the global agricultural sector is extensively
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using breeding tools aﬀorded by modern biotechnology.12,13
Over the past 80 years, improved crop varieties have accounted
for half of all improvements in agricultural productivity with, for
example, U.S. crop yields increasing by 2.5−4-fold for cotton,
soybean, and wheat and an amazing 70-fold for maize.10 A
dramatic increase in wheat and rice yields, targeted for use in
the developing world, was a central part of the “Green
Revolution”.14
Agricultural biotechnologies oﬀer an unprecedented capa-
bility to greatly accelerate improvements in crops, especially for
traits that are lacking in crop genomes. These traits include
insect, herbicide, and disease resistance, salt and drought
tolerance, and enhanced use of nitrogen as well as quality traits
such as increased β-carotene. These traits can improve
nutritional quality and reduce the need for agricultural inputs
such as fertilizers, pesticides, and water, which is particularly
useful for smallholder farmers who may not have easy access to
these inputs. Importantly for global adoption and development
work, GM crops are scale-neutral, with developing world
farmers being the biggest adopters in terms of both number of
farmers and land area.1
Recently, the 2014 IUPAC International Congress of
Pesticide Chemistry (San Francisco, CA, USA; August 2014)
included a symposium on “Challenges Associated with Global
Adoption of Agricultural Biotechnology”. Topics addressed by
symposium presenters included (i) poor public understanding
of GM technology and the need for enhanced communication
strategies, (ii) nonharmonized and prescriptive regulatory
requirements, and (iii) limited experience with regulations
and product development within some public sector programs.
The need for holistic resistance management programs to
enable the most eﬀective use of insect-protected crops and to
address adaptive pests was also a point of emphasis. It was
considered at the symposium that challenges to the adoption of
modern agricultural biotechnology may disproportionately
aﬀect developing countries, as well as smaller entrepreneurial
and public sector initiatives. This paper reviews the symposium
discussion and provides background information that can be
used to support further adoption of beneﬁcial crops developed
through modern agricultural biotechnology.
At the symposium, Huesing and Braverman showed that
programs to enable adoption of GM crops globally and through
public sector initiatives are already in place. In this paper,
Huesing provides an overview of the U.S. Agency for
International Development (USAID) “Feed the Future”
program and its role in supporting the global development of
agriculture sectors. Braverman describes the Interregional
Research Project Number 4 (IR-4) Project, a pathway for
public sector biotechnology registration in the United States
that has been successfully leveraged by academic groups.
Subsequent sections of the paper highlight challenges in GM
adoption. Shelton provides examples where GM cultivation has
been suspended despite clear evidence of it success. Felsot
highlights some of the misconceptions about GM technology
that can provoke public concern as well as moratoriums of the
type addressed by Shelton. Several symposium presenters
(Andres, van Rijssen, and Burns) comment on the demands
required by some regulatory systems and challenges in
establishing regulatory expertise in developing countries.
Finally, Hellmich and Reynolds stress the importance of
developing eﬀective, holistic insect resistance management
programs that can enable broader cultivation of insect-
protected (Bt) corn hybrids.
■ ENABLING GLOBAL ADOPTION
Three-fourths of the world’s chronically poor and hungry live
and farm in rural areas of developing countries, particularly in
sub-Saharan Africa.7,8 There is broad consensus that economic
growth originating in the agricultural sector is one of the most
eﬀective routes for increasing incomes of the rural poor, yet
<5% of development assistance and public spending targets
agriculture in these countries.8 “Feed the Future” is the U.S.
government’s hunger and food security initiative to address
global hunger. Focused on smallholder farmers, particularly
women, “Feed the Future” supports partner countries in
developing their agriculture sectors to accelerate economic
growth, increase incomes, and reduce hunger, poverty, and
malnutrition. Led by the U.S. Agency for International
Development (USAID), “Feed the Future” works with agencies
across the U.S. government using a “whole of government”
approach to partner with other governments, donor organ-
izations, the private sector, and civil society to enable its long-
term success.
USAID supports the development, release, and stewardship
of improved GM crops at all stages of the product development
pipeline. USAID has substantial involvement in providing
oversight in all aspects of the regulatory approval and
stewardship phases of projects in which it invests. USAID has
statutory requirements to ensure that the environmental
consequences of USAID-funded activities are identiﬁed and
considered by USAID and the host country prior to a ﬁnal
decision to proceed and that appropriate environmental
safeguards are adopted. Accordingly, USAID requires that all
regulatory submissions related to GM crops developed with
USAID funding comply with internationally accepted standards
as exempliﬁed by the Codex Alimentarius and U.S. regulatory
agencies.
To support its goals, parallel investments in partner countries
assist with building eﬀective regulatory systems and ensuring
that decision makers have the resources they need to make
informed decisions about biosafety. In addition, extensive
regulatory training and support of product developers ensures
appropriate safety measures are taken while GM crops are
moved through the regulatory process. To meet this latter
challenge, USAID has recently refocused eﬀorts to ensure that
in-country capacity is developed to ensure quality regulatory
data packages.
Multinational commercial seed companies are organized and
resourced to successfully meet GM product development
challenges.15 In particular, they possess the necessary human
resource skill sets to successfully orchestrate these complex
regulatory operations. Conversely, public−private partnerships
(PPP), which are largely driven by research institutions, are not
generally organized or staﬀed with regulatory professionals. To
address this issue, USAID works with development partners to
identify expert consultants (primarily industry regulatory aﬀairs
retirees) who have extensive proven hands-on experience in
developing and submitting regulatory dossiers for GM crops.
These experts work hand-in-hand with in-country product
developers to build the needed capacity and expertise in the
regulatory sciences so that partner countries and institutions,
primarily the National Agricultural Research Institutions
(NARIs), will have the expertise to develop and submit strong
regulatory dossiers that lead to commercialized crops targeted
for the beneﬁt of their low-resource farmers. This approach,
comprising the development of host country governmental
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regulatory expertise combined with the development of
regulatory aﬀairs expertise in national research institutions,
will provide developing partner countries with the capability to
develop GM crops targeting their speciﬁc needs in a safe,
transparent, and expeditious manner.
Regulatory approval of public sector biotechnology research
meant for commercial release is still one the major barriers
between research and availability of technologies to growers.
Unfortunately, as pointed out by Braverman, most biotechnol-
ogy research ends with only a journal publication due to a lack
of resources, product development and regulatory experience,
and professional reward for such eﬀorts. Furthermore, the time
and expenses involved are beyond the means of most
researchers and are frequently outside the scope of their parent
organization. For example, a large number of trait events have
been developed by researchers but only a small number of
petitions have been submitted and approved for deregulation,
and very few of those have been in specialty or minor
crops.16,17 About a decade ago the Specialty Crops Regulatory
Initiative18 was formed to address this issue, but without
funding and without any regulatory staﬀ, they have not secured
any registrations or even made a submission to the U.S.
Environmental Protection Agency (EPA).
Since 1963, the Interregional Research Project Number 4
(IR-4) has developed data, primarily on residue studies of
conventional chemistries, to obtain U.S. EPA pesticide
registrations. IR-4 was formed due to the lack of ﬁnancial
incentive by major companies to develop pesticide registrations
for specialty crops. In 1982, regulatory assistance was expanded
to cover biopesticides because of the history of regulation of
Bacillus thuringiensis (Bt) microbial pesticides and initial
biotechnology eﬀorts focusing on Bt Cry proteins. IR-4 had
extensive experience with microbial pesticides; therefore, the
extension to biotechnology registrations based on these same
microbes, as well as to other traits, was natural. Similar to
conventional chemicals, major manufacturers have focused on
maize, cotton, and soybeans rather than fruits and vegetables,
thus providing an area of focus for IR-4. Funded primarily
through the National Institute of Food and Agriculture
(NIFA),19,20 the IR-4 Project is able to provide guidance,
consultation, and submission of documents. IR-4 has
successfully assisted in the U.S. EPA registration of Honeysweet
Plum, a genetically engineered plum resistant to plum pox
virus.21 IR-4 also assisted in some of the initial phases of RNAi
work on the Israeli Acute Paralysis Virus aﬀecting bees. More
recently, IR-4 has taken on additional projects on tomato,
walnuts. and roses.
■ SCIENTIFIC MISUNDERSTANDING: CAUSES AND
CONSEQUENCES
Shelton described how he and his colleagues who are trying to
improve pest management have been frustrated to witness
campaigns against GM crops. The often inaccurate information
disseminated in such campaigns is galling to them because
these pest management crops have undergone strict safety
testing15 and have dramatically reduced pesticide inputs.2
What are the roots of such campaigns? Sociologists would
argue that cultural politics plays an important role in shaping
our political, economic, and social values. Many who advocate
against GM crops identify with anticorporate organic “natural”
agriculture. This anticorporate sentiment is often expressed by
those who claim to fear corporate control of the food system or
believe that corporations will put proﬁt ahead of corporate
responsibility in society’s most basic need.
Of direct relevance to global adoption, diﬀerences in the
perceptions of the value of GM crops are evident between
developing countries, where agriculture plays a prominent role
in the daily lives of the majority of people, and industrialized
countries, where only a small proportion, <2% in the United
States, is involved in agricultural production. This is one of the
reasons that the area grown to GM crops in developing
countries now exceeds that grown in industrialized countries.1
But even between industrialized countries that have high living
standards there are diﬀerences in perceptions about GM crops.
In Cultural Politics and the Transatlantic Divide over GMOs
Stephan22 suggests that Europeans, more so than Americans,
connect agriculture to positive images of “nature”. As such, they
are more likely to associate agricultural biotechnology with
broader and “troubling cultural and socio-economic changes”
than are Americans, who are more likely, despite some
opposition, to be more pragmatic. As observed later (Andres,
Burns) cultural factors strongly inﬂuence the diﬀerences in
regulatory frameworks adopted in Europe and in the United
States.
Despite these cultural diﬀerences about GM crops and
campaigns of disinformation to discredit them, their adoption
rate globally continues to increase.1 However, it should be
pointed out that the presently commercialized GM crops have
almost exclusively been industrialized crops including soybean,
maize, cotton, and canola. The reason for this is largely due to
the costs of developing and stewarding them. The adoption of
GM vegetables and fruits has accordingly lagged in comparison.
Except for small amounts of GM insect-resistant sweet corn and
disease-resistant squash and papaya, there has been minimal
development of GM technology for fresh food crops. This is
unfortunate because 45% of the value of all insecticides is
applied to fruits and vegetables,23 an amount that greatly
exceeds the combined insecticide use on maize, cotton, and
rice.
Fruits and vegetables are food crops, so there is increased
sensitivity about their production and continued misunder-
standing about how GM technology can be used to beneﬁt
their production. Thus, they are susceptible to campaigns to
limit their adoption, in both industrialized and developing
countries. Two recent examples illustrate this point: GM
papaya in Hawaii and GM eggplant in India, Bangladesh, and
the Philippines.
GM papaya was introduced in 1998, saving the Hawaiian
papaya industry from the devastating papaya ringspot virus
(PRSV) disease. PRSV is spread by aphids that feed on infected
papaya trees. Trying to control the aphid with insecticides is
ineﬀective and environmentally damaging. Notably, GM papaya
was developed by a native Hawaiian, and USDA Agricultural
Research Service (ARS) scientist, without any proﬁt to the
developer or a corporation, by incorporating a fragment of the
virus into the papaya genome to prevent virus replication.24
The GM papaya was distributed free to farmers, most of whom
are small-scale, multigeneration Filipino farmers, and now it is
estimated that 85% of all the papaya grown in Hawaii is GM.
However, in 2013 legislation was introduced to ban all GM
crops, including papaya, on the Big Island of Hawaii. Shelton
visited the Big Island in 2013 and found that this legislation was
the result of a well-organized disinformation campaign. The
inaccurate information about GM crops heard at the public
hearings was widespread and voiced largely by outside interests.
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The result was a law that went into eﬀect on March 3, 2014, to
ban all GM crops, except GM papaya, on the Big Island. GM
papaya was excluded from the ban because it had allegedly
“contaminated” the island and “could not be removed because
it was so widespread”. The law, however, is being challenged,
and its fate is uncertain.25
In India, Bangladesh, and the Philippines, a similar campaign
was waged against commercialization of insect-resistant egg-
plant. Eggplant is a common vegetable in these countries and is
attacked by a caterpillar known as the eggplant fruit and shoot
borer. Farmers commonly spray insecticide several times a
week to protect their crop. The insecticides used are broad-
spectrum and applied by workers who may not wear personal
protective equipment. The hazards to the workers, consumers,
and the environment are well documented.26,27 Beginning in
early 2000s, eﬀorts were initiated to develop insect-resistant
eggplant by having it express a bacterial protein (Bt) similar to
that in currently commercialized insect-resistant cotton and
corn. After a decade of development and laboratory and ﬁeld
trials and passing all requirements by regulatory agencies, Bt
eggplant was positioned to become the ﬁrst GM food crop in
India. However, because of a reported $100 million dollar
campaign by a multinational non-governmental organization
(NGO), the Minister of the Environment and Forests put a
moratorium on its commercialization on February 9, 2010. A
similar bank was upheld in the Philippines.72The result is that
farmers in a developing country cannot access a safe,
economically beneﬁcial, and healthy product.26,27
In Bangladesh, the government approved Bt eggplant to be
conditionally cultivated and sold on a commercial basis starting
in 2014. Initially, Bt eggplant was grown in 20 farmer ﬁelds
beginning in January with an additional 108 farms in 2015.
Despite a campaign of opposition, farmers overall are
supportive of Bt eggplant.28 Today, proactive initiatives to
highlight the value of modern agricultural biotechnology and
science to enable solutions to food security and safety are
appearing. An example is the Bill & Melinda Gates funded
project, the Cornell Alliance for Science, whose goal is to help
inform the debate about biotechnology in agriculture.
As pointed out by Felsot, public lack of familiarity with
biotechnology and agriculture has arguably led to feelings of
uncertainty about GM crops. Citizen initiatives in several
American states and counties therein may be attempts to
absolve this uncertainty by mandating the use of labels
declaring a food genetically engineered and/or the outright
banning of planting such crops.29,30 These initiatives typically
invoke some form of the precautionary principle (PP)31 to
reject GM crops based on a perceived absence of deﬁnitive
proof of safety, a goal that scientiﬁcally is unattainable. As noted
by Shelton above, the PP is often tied to identity politics best
illustrated by the GM debate in the European Union (EU).
Invoking the PP in EU policy, for example, has brought a near
lockout of grower cultivation of GM crops in Europe, but
interestingly, not a ban on import of such material for food and
feed uses.32 EU policy against cultivation of GM crops may be
based on arguments that McHughen suggests are “marked with
much ignorance and misinformation”.32 Felton described ﬁve
misconceptions around GM technology that illustrate the
inappropriate invocation of the PP to risk management of
agricultural biotechnology.
Misconception 1: U.S. Policies for Regulating GM
Crops Are Inferior to the PP-Driven Policies of the EU. In
fact, the United States and EU33 both require premarket risk
assessment of GM crops with the only diﬀerence ultimately
being the architecture of the statutory mandates. In the EU, the
PP is invoked in policy directives as a philosophical imperative
but is not explicitly deﬁned. The U.S. regulatory system
involves three regulatory agencies (USDA, FDA, and EPA) that
operate under separate statutes but within a Coordinated
Framework for the Regulation of Biotechnology under 51 FR
23302.34 In the U.S. system precaution is an important policy
component. For example, a permit from USDA is required
prior to the ﬁeld testing of new GM events. Only after a plant
pest risk assessment and a formal environmental assessment, as
required under the National Environmental Policy Act
(NEPA), will USDA declare an event to have “non-regulated”
status, which obviates the need for permitting and paves the
way for commercialization. The U.S. EPA regulates crop traits
classiﬁed as plant-incorporated protectants (PIPs) under the
statutory mandates of FIFRA (Federal Insecticide Fungicide
Rodenticide Act) (see Hellmich and Reynolds later). In
addition, EU regulations for traceability and postmarket
surveillance are analogous to FIFRA section 6(s)(2) rules on
“adverse eﬀects reporting”.
Misconception 2: Gene Transfer Is Not Natural.
Horizontal (or lateral) gene transfer is presently recognized
as a naturally important phenomenon in biological evolution,
especially among prokaryotes.35 The phenomenon has been
estimated to occur in 50−60% of bacterial and archaeal taxa
and among 10% of eukaryotes.36 Some at the symposium
suggested that, accordingly, plant breeders have simply added
this naturally occurring process to the plant breeder’s toolbox.
In other words, what genetic engineering oﬀers to plant
breeding is a very precise means of transferring useful genes to
crops for traits that may simply not exist in the crop gene pool,
for example, drought tolerance or insect resistance. Com-
paratively speaking, the highly precise nature of genetic
engineering may be far more attractive for some traits than
the much less precise method of, for example, mutation
breeding, widely used for crops including those cultivated in
organic agriculture.37 Felsot further added that the fact that
Agrobacterium tumefaciens can transfer a functional virulence
gene to a host plant’s genome is an ironic testament to a case
for the “naturalness” of genetic engineering given that species’
importance to genetic engineering. This can be now highlighted
by the recent ﬁnding that sweet potato is a naturally transgenic
food containing Agrobacterium T-DNAs with expressed genes.38
Misconception 3: GM Crops Do Not Yield Beneﬁts.
Independent studies show economic beneﬁts to farms from
yield increases while showing reductions in environmental
impact.39−41 Protestations of signiﬁcant increases in pesticide
use, especially of herbicides, based on singular analyses,42 are
refuted by other studies of pesticide use decreases or
nonstatistically signiﬁcant increases.2,26,27 Studies have also
documented decreases in worker poisonings from insecti-
cides.43 Overall, the data are very clear on the yield and safety
beneﬁts of GM crops to growers best illustrated by the level of
adoption of these GM varieties in both the developing and
developed worlds.1
Some presenters at the symposium further considered that
the argument should not simply be around the issue of
increases or decreases in the abundance of a particular
compound in the environment per se. It should be around
issues such as precision, safety, and eﬃcacy. If, for example, an
increase in a relatively safe herbicide results in a signiﬁcant
decrease in soil erosion or emission of climate-degrading gases,
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then the use of that compound, if safe for the intended use,
should be an option of choice. Likewise, for an insecticidal GM
trait the overall increase in environmental safety in terms of
eﬀects on nontarget organisms or ecosystem services has been
very positive. Using that approach, it is clear that the use of
many GM traits is more benign than other production options.
In many cases, the use of harmful pesticides is replaced with
safer pesticides, and their application is more precise, thereby
increasing applicator and consumer safety.
Misconception 4: GM Product Labeling Provides
Consumers with Choice. Globally, there are diﬀerent
approaches to GM product labeling.44 The EU policy of
requiring GMO labeling is held as an example of the PP and a
moral principle of the “right to know”. Products that
intentionally use GM derivatives must be labeled in the EU,
but labeling requirements are threshold-based (e.g., adventi-
tious presence of 0.9% GM does not require labeling).
Monitoring of various products containing soybeans or corn
shows signiﬁcant percentages of unlabeled food or feed
containing GM biomarkers below country-established thresh-
olds.45−48 Conversely, products that contain ingredients
derived from a GM source but that are not identiﬁable as
GM by analysis require labeling in the EU as a means to
provide evidence of GM traceability. Thus, GM labeling
extends to highly reﬁned products such as vegetable oil or
sugar, in which the GM DNA or resulting protein is no longer
present or detectable.
Misconception 5: PP-Based Management Fosters
Democratization of Technology. The U.S. risk assessment
framework and regulatory data requirements guide what studies
are required for risk characterizations that inform risk
management. The deregulation and approval process is costly,
and many universities or other nonproﬁt entities are unable to
fulﬁll the rgulatory burden necessary to commercialize new
biotechnology-derived cultivars despite beneﬁts for health,
environmental resiliency, and energy production.49,50 Thus, the
rigor of the regulatory process has centralized crop breeding
rather than democratized it.
If opposition to GM technology is indeed based in
“ignorance and misinformation”, how can the above mis-
conceptions be dispelled? A key will be addressing public
perceptions through improved communication and educational
eﬀorts in schools that emphasize modern biological subjects.
For now, however, application of the PP has not increased
environmental or health safety and has needlessly delayed the
introduction of safe and useful crops: a goal of the educational
eﬀort should be to explain why a “precautionary approach” to
regulation is a more practical approach than the poorly
operationalized precautionary principle.
■ REGULATORY ISSUES
Earlier, Huesing observed that regulatory challenges extend to
infrastructure and knowledge gaps in developing functioning
biosafety programs in developing countries. As pointed out by
Jansen van Rijssen, the creation of regulatory frameworks for
adopting GM crops has been a slow process in Africa. South
Africa, with established GMO legislation since 1997, has often
been held as an example of good GMO governance and the
entrance to GMO production in Africa. However, South Africa
has limitations in approving GMO permits, and its experiences
may provide important lessons for other developing countries.
The South African government has approved nine GM
events for general release since 1997, and the technology
owners are multinational companies. A number of events from
national research and academic institutions were not approved.
The reasons given, in a number of cases, were socio-economic
and trade issues but also included environmental and food
safety. The appeals by the applicants against government
decisions resulted in increased permit conditions such as more
stringent contained experimental requirements. In some cases
research was discontinued or taken elsewhere. Investing in local
research has become less attractive because of increased
expenses and long delays. This situation directly or indirectly
results in researchers resigning or turning to diﬀerent avenues
of research.
Because of this situation, the question arose: What was South
Africa doing wrong? To seek an answer, Jansen van Rijssen and
colleagues started by analyzing South African risk governance of
GMOs. South African legislation resembles the Codex
Alimentarius model of risk governance except for the most
transparent phase of risk assessment policy development. The
GMO Act of South Africa provides for a GMO Executive
Council and an independent GMO Advisory Committee. The
council members represent diﬀerent relevant government
departments, each with its own mandate; decisions require
consensus agreement from the council members. Mandates of
the government departments may have conﬂicting purposes;
for example, food security may be more emphasized than
environmental protection. In addition, each government
department requires an individual assessment of the doc-
umentation by its regulatory scientists in addition to the
reviews by the expert advisory committee. Role conﬂicts have
not been resolved despite the noble intentions of the national
biotechnology strategy in the past. However, a new
bioeconomy strategy announced in 2014 may be more
successful. The GMO advisory committee, in turn, consists of
academics and independent scientists. These prestigious
appointments, unfortunately, demand time-consuming dedi-
cation without adequate remuneration. Peer reviewing for risk
assessment is an important requirement to ensure credibility,
but has many challenges. The number of independent scientists
(e.g., experts in environmental risk assessment, plant breeding,
animal scientists, and toxicologists) that are qualiﬁed and
willing to review applications for permits, that are speciﬁcally
related to food safety and environmental safety, is limited. A
shortage of toxicologists, a scarce skill, creates great concern,
aﬀecting sectors of agriculture, food/animal safety, environ-
mental safety, and pharmaceuticals. The newly approved
bioeconomy strategy of South Africa places an even greater
demand on scarce skills.
The committee scientists do not have suﬃcient opportunities
to gain international exposure to bodies such as the Codex
Alimentarius, UNEP, and the Organization for Economic
Cooperation and Development (OECD). These are mostly
reserved for policy makers and government regulatory
scientists, who are, in the case of South Africa, not considered
as expert advisors. International exposure to particularly the
approaches to risk assessment is, therefore, limited or almost
nonexistent. Academics are constrained by a narrow focus on
specialized ﬁelds of research, not directed at a risk assessment
approach. Training in risk assessment is therefore of great
importance. Unfortunately, funding of such interactions,
internationally and nationally, remains problematic. In a
study51 conducted with a number of scientists familiar with
the regulatory process, one of the main issues identiﬁed was
improved communication between decision makers and
Journal of Agricultural and Food Chemistry Perspective
DOI: 10.1021/acs.jafc.5b05116
J. Agric. Food Chem. 2016, 64, 394−402
398
stakeholders. Speciﬁcally, the legislated introduction of
structured communication could contribute to a solution.
Such an interface between the council members (decision
makers), the committee, and stakeholders should be consid-
ered. The interface could foster scientiﬁc collaboration, provide
for interaction with a number of additional scientists, provide
policy development for improving regulatory training, and
provide a foundation for scientiﬁc framing of reviews and other
matters related to GM crop regulation of importance in a
participative and transparent manner. This could be a step
forward toward, in time, reducing delays and expediting the
approval of new GM events.
There have also been many expressed concerns about
regulatory systems in developed countries. The demonstrated
safety of the GM process is reﬂected in the approach to
regulation used by some agencies, for example, in Canada, but
less so elsewhere. The Canadian regulatory approach is
product-based and covers plants with a novel trait (PNT)
suﬃciently diﬀerent from those of the same or similar species,
regardless of the breeding method used in their development.
PNTs include GM crops as well as some produced by more
conventional breeding techniques. Other agencies have
provided increasingly prescriptive and country-speciﬁc require-
ments. Andres commented on the European regulatory
environment, which he considered to be highly politicized,
and described some of the prescriptive requirements of the
European Food Safety Authority (EFSA), which have provided
a major challenge for GM developers. EFSA makes available
guidelines that provide information on the risk assessments that
must be submitted to support applications for approval for food
and feed use and for cultivation in the EU of GM crops.
Although these guidelines allow a case-by-case evaluation of
each product, there are very prescriptive requirements
regarding how the data must be generated and analyzed (e.g.,
following highly speciﬁc statistical approaches including both
diﬀerence and equivalence testing), and they are not in line
with other international regulatory frameworks. These require-
ments represent a major challenge for developers as any GM
product entering the EU for food, feed, or processing must be
approved and for that, regulatory packages must comply with
these data requirements, but not only in terms of which data
must be provided but also in terms of how the data must be
generated. This prevents, in most cases, data transportability.
Regulatory packages are constructed following the EU rules,
thus adding considerable cost and resources without providing
data that are more informative for risk assessments. This results
in diﬀerent regulatory packages for the EU and the rest of the
world. Moreover, the European Commission has now made
this guidance legally binding in implementing regulation.
Together with the systematic voting of a number of Member
States against EFSA opinions, Andres, representing EuropaBio
(European Association for Bioindustries), considers that the
EU has developed into one of the most convoluted and
unpredictable regulatory frameworks for the authorization of
GM crops in the world.
Challenges of onerous regulatory data generation were also
addressed by Burns, who argued that the proven hypothesis-
driven problem formulation approach used globally oﬀered
advantages over prescriptive data-gathering approaches. As she
observed, GM crops undergo extensive testing prior to
commercialization to test the hypothesis that their cultivation
poses negligible risk to the environment. Testing is directed by
problem formulation. Conceptual models are helpful tools for
identifying testable risk hypotheses during problem formulation
and can be tailored to the GM crop and its intended use. Risk
hypotheses can then be tested by collecting information from
the literature and/or by generating new data.
When conceptual models for potential eﬀects to nontarget
organisms are developed, both hazard and potential exposure
should be considered. The mode of action of the novel
protein(s) produced by the genetically modiﬁed crop can
inform hazard. The natural presence of that class of protein in
the environment can inform whether prior environmental
exposure has occurred and the intended use of the crop, that is,
cultivation or import for food and feed use, can inform
exposure associated with the GM crop. If the novel protein’s
mode of action is not related to toxicity and if similar proteins
are abundant in the environment and known to be of low
hazard to nontarget organisms, then it can be concluded that
the cultivation of a crop producing that novel protein poses
negligible risk to nontarget organisms, including soil microbes.
In all cases, environmental exposure related to the import of
grain for food and feed use is limited compared to exposure via
cultivation. The only plausible scenario by which environmental
exposure of genetically modiﬁed crop grain may occur is via
accidental spillage, which can be mitigated by cleaning up
spilled seeds. If seeds germinate, then environmental exposure
to the crop is still likely to be spatially and temporally isolated.
Therefore, a properly conducted environmental risk assessment
(ERA) for cultivation of the GM crop also should satisfy the
ERA for importation of the same crop product for food and
feed use. In summary, problem formulation driven by science-
based hypotheses is essential for developing a case-by-case
approach to evaluate the safety of GM crops.
■ ENABLING INSECT MANAGEMENT PROGRAMS
The majority of GM crops have been developed as pest
management tools, including the safe management of tradi-
tionally diﬃcult to control insect pests. GM corn hybrids that
target an important moth pest, the European corn borer,
Ostrinia nubilalis Hübner, were ﬁrst commercialized in 1996.
These plants produce insecticidal crystalline (Cry) toxins,
derived from B. thuringiensis (Bt). Bt corn has revolutionized
how major corn insect pests are managed, but insect resistance
management (IRM) strategies are essential for delaying pest
resistance to the Cry toxins. Currently, preventive IRM is based
on the high-dose/refuge (HDR) strategy52,53 (Figure 1), which
comprises three basic components: (i) resistance alleles must
be rare and recessive; (ii) the Bt toxin must be delivered at a
dose high enough to render heterozygotes functionally
recessive, that is, kill 99.99% of susceptible insects; and (iii) a
non-Bt corn refuge should be grown near Bt corn that produces
an excess of homozygous susceptible individuals to mate at
random with rare resistant individuals. This strategy appears to
have been successful in delaying resistance to Cry1 Bt toxins in
European corn borer,54 and no evidence of ﬁeld-evolved
resistance has been detected after 18 years of Bt corn
cultivation. The continued eﬀectiveness and high adoption of
Bt corn has led to a documented area-wide suppression of corn
borer populations across the Corn Belt.55
In 2003, Bt corn hybrids were introduced that expressed the
Cry3Bb1 toxin targeting the corn rootworm complex
(Diabrotica spp.). The eﬀectiveness of these hybrids led to
rapid adoption by growers. However, currently available
Cry3Bb1, Cry34/35Ab, and mCry3A Bt corn hybrids do not
satisfy high-dose criteria.56,57 In addition, resistance alleles in
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western corn rootworm (WCR), Diabrotica virgifera virgifera, to
Cry3Bb1 are probably less rare and incompletely recessive.56−58
As a consequence, ﬁeld resistance to Cry3Bb1 Bt corn evolved
quickly and was conﬁrmed in parts of Iowa less than seven
years after its introduction.59 Cry3Bb1-resistant WCR
populations have now been documented in other states,56,60
as well as populations cross-resistant to the modiﬁed Cry3A
(mCry3A) Bt toxin.61
Resistance also has been documented among several
lepidopteran species including the African stem borer, Busseola
fusca, in South Africa,62 and the fall armyworm, Spodoptera
frugiperda, in Puerto Rico63 and Brazil.64 In all of these cases,
toxin levels in Bt corn were not high-dose (Figure 1). These
documented cases of ﬁeld resistance have highlighted two
major challenges to IRM relying on the HDR strategy: (i) Bt
corn is not high dose for all target insects, and (ii) grower
compliance for implementing the HDR strategy (i.e., planting
and placement of refuges) in some regions is low.65,66
As part of its regulation of IRM for Bt crops, the U.S. EPA
requires resistance monitoring for the major target pests of corn
and cotton.67 For corn rootworm (CRW) monitoring has
consisted of two main components: (i) investigation of reports
of unexpected ﬁeld damage and (ii) monitoring for changes in
susceptibility through targeted population sampling and testing.
Unexpected damage reports may reveal the occurrence of
localized resistance (or hot spots) before the eﬀects become
widespread. Targeted ﬁeld sampling can reveal changes in
susceptibility of geographically representative populations. In
both cases, bioassays are used to determine the susceptibility of
each sampled population. If resistance in sampled populations
is conﬁrmed in laboratory bioassays, a remedial action plan is
triggered to mitigate the resistant population and ensure trait
durability.
Resistance monitoring is conducted each year by Bt corn
registrants and, for CRW, has been coordinated through the
Agricultural Biotechnology Stewardship Technical Committee
(ABSTC) with annual reports submitted to the U.S. EPA.68
CRW presents a number of challenges for resistance
monitoring. The insect has one generation per year, undergoes
obligate diapause, and feeds subterraneanly, factors that limit
the ability to conduct susceptibility bioassays. CRW are also, as
mentioned earlier, generally less sensitive to Bt toxins than
other target pests of Bt corn (e.g., Lepidoptera). These factors
can complicate both ﬁeld scouting and interpretation of
bioassays. Timing is also a concern; because of obligate
diapause, a sampled population may not be tested (and
determined to be resistant) until the following season.
Overall, in light of the challenges presented by CRW, the
U.S. EPA has concluded that the current resistance monitoring
program is reactive rather than proactive.68 Shifts in
susceptibility (prior to ﬁeld failure) are not likely to be
detected with current approaches. Rather, resistance will more
likely be detected through the investigation of Bt ﬁeld damage.
Indeed, several researchers have reported detecting CRW
resistant to Cry3Bb1 by testing populations collected from
damaged ﬁelds with on-plant assays.51,59,69 It should be noted
these cases of resistance were not identiﬁed through the annual
ABSTC monitoring eﬀorts based on random population
sampling and diet bioassays.
The U.S. EPA is concerned about the reports of CRW
resistance to Bt corn, as resistance may increase the use of
conventional insecticides and increase the vulnerability of more
durable traits in pyramided products with a reduced refuge. In
December 2013, the U.S. EPA convened a Science Advisory
Panel (SAP) meeting to address scientiﬁc issues associated with
CRW resistance monitoring and provide recommendations.70
The U.S. EPA agrees with most of the panel recommendations
and notes that industry has already implemented a number of
these.71 Input was also provided from other aﬀected stake-
holders including corn growers, grower associations, crop
consultants, farm bureaus, crop protection industries, extension
entomologists, and independent researchers via a public docket.
The Agency plans to work with ABSTC to implement
additional improvements for subsequent growing seasons.
Overall, the measures taken by the U.S. EPA will be
important in informing improved steps to IRM, especially in
global regions seeking access to Bt crops.
■ CONCLUDING REMARKS
Global adoption of GM crops has been slowed by many societal
factors, many of which appear to be more pervasive in some
geographic regions than in others. Factors discussed at the 2104
IUPAC symposium on “Challenges Associated with Global
Adoption of Agricultural Biotechnology” included (i) poor
public understanding of GM technology and the need for
enhanced communication strategies, (ii) nonharmonized and
prescriptive regulatory requirements, and (iii) limited experi-
ence with regulations and product development within some
public sector programs. The need for holistic resistance
management programs to enable the most eﬀective use of
insect-protected crops and to address adaptive pests was also a
point of emphasis.
Despite the infrastructure and resources available to support
the development of the agriculture sector globally, adoption of
agricultural biotechnology still faces constraints. Many of these
challenges can be attributed to complex regulatory systems but
are generally symptomatic of a high level of misinformation and
misconceptions surrounding modern agricultural biotechnol-
ogy. Overall, however, it is clear that adoption of modern
agricultural biotechnology has not only provided beneﬁts to
growers and consumers but has great potential to provide
solutions to an increasing global population and diminishing
agricultural land. It was a major conclusion of the symposium
that this potential will be realized by continued scientiﬁc
innovation, harmonized and practical regulatory systems, and
Figure 1. Dose mortality graph that demonstrates the importance of
high-dose toxin in genetically engineered crops. With high dose (1)
most if not all susceptible (SS) and heterozygous (RS) insects are
killed; only the few resistant (RR) insects survive. However, with low
dose or “not high dose” (2) many of heterozygous insects survive in
addition to resistant insects. Resistance develops much more quickly
with low-dose crops because most resistance genes (R) are carried by
heterozygous insects.
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broader communication of the beneﬁts of the high-yielding,
disease-resistant, and nutritionally enhanced crops attainable
through modern biotechnology.
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